SCHEMBL6009567

SCHEMBL6009567

COc1cc(-c2cccc(Cl)c2)c2cc(C(=O)c3cncn3C)ccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.41
LTB4R Q15722 2/20 0.41
FNTA P49354 5/20 0.39
FNTB P49356 5/20 0.39
NR1I3 Q14994 1/20 0.37
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36
TUBB6 Q9BUF5 1/20 0.36
TUBB2B Q9BVA1 1/20 0.36
TUBB1 Q9H4B7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12590512 0.87 LTB4R (0.42) LTB4RFNTAFNTBNR1I3TUBB4A
SCHEMBL5656596 0.83 LTB4R (0.46) LTB4RNR1I3TUBB4ATUBBTUBA3C
SCHEMBL5026990 0.81 CSNK2A2 (0.45) IDO1FNTAFNTBHPDCSNK2A2
SCHEMBL5655139 0.81 LTB4R (0.44) LTB4RNR1I3TUBB4ATUBBTUBA3C
SCHEMBL5657985 0.80 LTB4R (0.43) LTB4RNR1I3TUBB4ATUBBTUBA3C
SCHEMBL6009561 0.79 FNTA (0.49) IDO1FNTAFNTBPGGT1B
SCHEMBL6009866 0.78 FNTA (0.61) FNTAFNTB
SCHEMBL6010167 0.78 LTB4R (0.42) LTB4RNR1I3TUBB4ATUBBTUBA3C
SCHEMBL5549184 0.78 LTB4R (0.42) LTB4RNR1I3TUBB4ATUBBTUBA3C
SCHEMBL6010415 0.78 RORC (0.58) FNTAFNTBRORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067531-B2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2006-06-27 US disclosed
US-20030199547-A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives JANSSEN-CILAG S.A. (FR) 2003-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030199547-A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives FNTA, FNTB, RCE1 IDO1 3817/4885LTB4R 1779/4885FNTA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.